NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with species-specific effects on NLRP3 and AIM2 inflammasome-mediated pyroptosis. It demonstrates potent inhibition of pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 μM. It also disrupts the interaction between NLRP3 or AIM2 and the adaptor protein ASC, effectively preventing ASC oligomerization and blocking inflammasome […]

NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with species-specific effects on NLRP3 and AIM2 inflammasome-mediated pyroptosis. It demonstrates potent inhibition of pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 μM. It also disrupts the interaction between NLRP3 or AIM2 and the adaptor protein ASC, effectively preventing ASC oligomerization and blocking inflammasome […]

SD-436 is a potent and selective PROTAC degrader of STAT3 with a DC50 of 0.5 μM. It induces complete and long-lasting tumor regression in leukemia and lymphoma xenograft models in mice.

NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with species-specific effects on NLRP3 and AIM2 inflammasome-mediated pyroptosis. It demonstrates potent inhibition of pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 μM. It also disrupts the interaction between NLRP3 or AIM2 and the adaptor protein ASC, effectively preventing ASC oligomerization and blocking inflammasome […]

NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with species-specific effects on NLRP3 and AIM2 inflammasome-mediated pyroptosis. It demonstrates potent inhibition of pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 μM. It also disrupts the interaction between NLRP3 or AIM2 and the adaptor protein ASC, effectively preventing ASC oligomerization and blocking inflammasome […]

G6PD activator AG1 is a small molecule activator of glucose-6-phosphate dehydrogenase (G6PDH) with an EC50 of 3.4 µM for G6PDH⁴⁵⁹ᴸ that enhances the activity of wild-type and mutant G6PD. It reduces oxidative stress in cells, zebrafish, and human erythrocytes, making it useful for research on G6PD enzymopathies.

G6PD activator AG1 is a small molecule activator of glucose-6-phosphate dehydrogenase (G6PDH) with an EC50 of 3.4 µM for G6PDH⁴⁵⁹ᴸ that enhances the activity of wild-type and mutant G6PD. It reduces oxidative stress in cells, zebrafish, and human erythrocytes, making it useful for research on G6PD enzymopathies.

G6PD activator AG1 is a small molecule activator of glucose-6-phosphate dehydrogenase (G6PDH) with an EC50 of 3.4 µM for G6PDH⁴⁵⁹ᴸ that enhances the activity of wild-type and mutant G6PD. It reduces oxidative stress in cells, zebrafish, and human erythrocytes, making it useful for research on G6PD enzymopathies.

G6PD activator AG1 is a small molecule activator of glucose-6-phosphate dehydrogenase (G6PDH) with an EC50 of 3.4 µM for G6PDH⁴⁵⁹ᴸ that enhances the activity of wild-type and mutant G6PD. It reduces oxidative stress in cells, zebrafish, and human erythrocytes, making it useful for research on G6PD enzymopathies.

GLPG3312 is a potent and selective inhibitor of pan-SIK, with an IC50 of 2.0 nM for SIK1, 0.7 nM for SIK2, and 0.6 nM for SIK3. It demonstrates anti-inflammatory and immunoregulatory activities in vitro in human primary myeloid cells and in vivo in mouse models.